Happel David
Sagimet Biosciences Inc. · President & CEO
Happel David is listed in public filings as director, officer: President & CEO. This Happel David insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Sagimet Biosciences Inc. (SGMT). Investors use Happel David's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $2.2M300k shares | Grant / ExerciseMay 28, 2026 | $2.2M300k shares | $7.27 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $1.4M256k shares | Grant / ExerciseFeb 19, 2026 | $1.4M256k shares | $5.38 | -- | |
| --805.6k shares | Grant / ExerciseFeb 19, 2026 | Disclosure amount unavailable128k shares | -- | -- | |
| $3.6M677.6k shares | SellFeb 10, 2026 | $64.9K12.1k shares | $5.36 | -- | |
| $6.3M689.7k shares | SellJul 21, 2025 | $598.1K65.5k shares | $9.13 | -- | |
| $2.2M472k shares | Grant / ExerciseFeb 6, 2025 | $2.2M472k shares | $4.71 | -- | |
| --755.2k shares | Grant / ExerciseFeb 6, 2025 | Disclosure amount unavailable116k shares | -- | -- |